Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Receivables: 2018-2024

Historic Change in Receivables for ADC Therapeutics (ADCT) over the last 6 years, with Dec 2024 value amounting to -$4.8 million.

  • ADC Therapeutics' Change in Receivables fell 90.65% to $4.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$47.8 million, marking a year-over-year decrease of 211.78%. This contributed to the annual value of -$4.8 million for FY2024, which is 90.02% up from last year.
  • ADC Therapeutics' Change in Receivables amounted to -$4.8 million in FY2024, which was up 90.02% from -$47.8 million recorded in FY2023.
  • In the past 5 years, ADC Therapeutics' Change in Receivables ranged from a high of $42.8 million in FY2022 and a low of -$47.8 million during FY2023.
  • In the last 3 years, ADC Therapeutics' Change in Receivables had a median value of -$4.8 million in 2024 and averaged -$3.3 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 241.48% in 2022, then crashed by 211.78% in 2023.
  • Over the past 4 years, ADC Therapeutics' Change in Receivables (Yearly) stood at -$30.2 million in 2021, then skyrocketed by 241.48% to $42.8 million in 2022, then tumbled by 211.78% to -$47.8 million in 2023, then spiked by 90.02% to -$4.8 million in 2024.